Diagnosed sarcoidosis patients in the Florida and Georgia regions are encouraged to participate in a new Clinical Trial Opportunity with the University of Florida in Gainesville! The purpose of this study is to investigate fibrocytes, specific cells in the blood which could indicate organ damage, in patients with sarcoidosis.
If eligible, patients will be given a blood test to identify if they will develop future scarring, and will have an MRI to assess whether there is any sarcoidosis-related scarring in their heart. The goal of this research is to develop tests that determine who should be treated and whether the treatment is effective.
Patients will be provided with the results of their MRI, which in turn can be shared with their own providers, if requested.
To be eligible for this study, patients must:
- Be diagnosed with sarcoidosis.
- Be 18 years of age or older.
More information can be found on the University of Florida Health’s website. Interested patients are also welcome contact the following site coordinator:
- Rosie Kizza, 352-273-7225, Rosie.Kizza@medicine.ufl.edu
Learn more about clinical trials for which you might qualify in our blog or visit www.clinicaltrials.gov.
Choosing to participate in a study is an important decision we encourage you to discuss with your physicians, family members, and friends. Every study comes with potential risks and benefits you should discuss thoroughly with you physicians and study coordinators.